RE:RE:Have a great New YearThe two negative catalysts that had an effect on the share price have no impact on the future of the company going forward. Based on the CE approval and that which was stated in the news release ( the company is now allowed to commercialize it's test throughout Europe and is ready to take firm orders ). In my opinion this will only put added pressure on the FDA and HC to approve the test. Something else that caught my eye in the NR was they are sending their tech to a manufacturer in the U.S. with the statement by Biden last week about using the act to compel manufacturers to manufacturer tests for the U.S. and by this company sending it's tech to a manufacturer in the U.S. it indicates to me maybe we will see this test approved in the U.S. sooner rather than later.